We Need Your Help!
A survey is presently being conducted by a graduate student from Western Carolina University on transportation and epilepsy. Participants need to be 18 and above with at least a two year history of epilepsy. Information from this survey will be very helpful in assessing the transportation issues that people with epilepsy face in our state. If you would be interested in participating in this survey contact: Patricia Gibson at the Epilepsy Information Service at 1-800-642-0500 or email:pgibson@wakehealth.edu
How to treat epilepsy
About antiepileptic medications
Epilepsy medications don't cure epilepsy, but they can reduce how often seizures occur, and can stop seizures completely in many people. There are approximately 30 different medications available for epilepsy treatment. The kind of medication right for a particular person depends on their epilepsy type, age and gender, use of other medications, other medical conditions, and a number of additional factors. People with epilepsy need to work closely with their physician to choose the right medication. For many, one of the newer medications can control seizures with fewer side effects than with older medications.
Many epilepsy medications are available as generics, which can greatly reduce the cost of treatment. For most people, generic epilepsy medications work just as well as name brand medications at a fraction of the cost. But a few people still require name brand medications to properly control seizures.
It is important to take medication as prescribed. A physician or pharmacist should advise on whether a medication should be taken with food, what to do in the event of a missed dose, and how the medication should be stored.
Treatments other than medication
IMPORTANT UPDATES
Diacomit Approved for the Treatment of Dravet Syndrome
The Food and Drug Administration (FDA) has approved Diacomit (stiripentol) for the treatment of seizures associated with Dravet syndrome in patients aged ≥2 years taking clobazam. Somnolence, decreased appetite, agitation, ataxia, weight loss, hypotonia, nausea, tremor, dysarthria, and insomnia were the most common adverse events reported with Diacomit. For more information contact the Epilepsy Information Service of Wake Forest School of Medicine, 800-642-0500.
Get more information
Epilepsy Alliance North Carolina
Piedmont One, Suite 5541 A
1920 W. First Street
Winston-Salem, NC 27104
Telephone: (800) 451-0694
Local: (336) 716-2320
Fax: (336) 716-6018
Email: PGibson@WakeHealth.edu